Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.53975
-0.0128 (-2.31%)
Sep 9, 2026, 11:30 AM EDT - Market open
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $8.3 million as of September 9, 2026. Its market cap has decreased by -36.87% in one year.
Market Cap
8.30M
Enterprise Value
3.28M
1-Year Change
-36.87%
Ranking
Category
Stock Price
$0.54
ChartMarket Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $8.30M, a decrease of -97.97%. That is a compound annual growth rate of -25.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 8.30M | -8.14% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 9.93M |
| Senti Biosciences Holdings | 9.81M |
| Ensysce Biosciences | 9.36M |
| GT Biopharma | 9.33M |
| Exicure | 9.03M |
| Imunon | 8.70M |
| CNS Pharmaceuticals | 8.61M |
| Soligenix | 8.35M |